A Phase II Trial of Cisplatin/Etoposide and Concurrent, Radiotherapy Followed by Paclitaxel/Carboplatin Consolidation For Limited Stage Small Cell Lung Cancer

Closed

Phase

Accrual

100%

Published

Abbreviated Title

CDDP+VP-16+RT -> Taxol/Carbo in SCLC

Activated

07/01/1998

Closed

08/01/1999

Research committees

Lung Cancer

Publication Information Expand/Collapse

2004

Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713

MJ Edelman;K Chansky;LE Gaspar;B Leigh;GR Weiss;SA Taylor;J Crowley;R Livingston;DR Gandara Journal of Clinical Oncology 22(1):127-132

2002

Phase II (SWOG 9713) trial of cisplatin/etoposide (PE) and concurrent radiotherapy (XRT) followed by paclitaxel/carboplatin (TC) consolidation for limited small cell lung cancer (LSCLC)

MJ Edelman;K Chansky;B Leigh;J Crowley;DR Gandara Proc of the American Society of Clinical Oncology 21:303a(#1210)

Other Clinical Trials

SWOG Clinical Trial Number

S2302

PRAGMATICA - LUNG: A PROSPECTIVE RANDOMIZED STUDY OF RAMUCIRUMAB (LY3009806; NSC 749128) PLUS PEMBROLIZUMAB (MK-3475; NSC 776864) VERSUS STANDARD OF CARE FOR PARTICIPANTS PREVIOUSLY TREATED WITH IMMUNOTHERAPY FOR STAGE IV OR RECURRENT NON-SMALL CELL LUNG CANCER

Research Committee(s)

Lung Cancer

Activated

03/06/2023

Accrual

77%

Open

Phase

SWOG Clinical Trial Number

A082002

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer

Research Committee(s)

Lung Cancer

Activated

12/21/2021

Open

Phase

SWOG Clinical Trial Number

CTSU/NRG-LU007

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial

Research Committee(s)

Lung Cancer

Activated

08/17/2020

Open